Search Results

You are looking at 71 - 80 of 199 items for :

  • "molecular markers" x
  • Refine by access: All content x
Clear All
E Patterson
Search for other papers by E Patterson in
Google Scholar
PubMed
Close
,
R Webb
Search for other papers by R Webb in
Google Scholar
PubMed
Close
,
A Weisbrod
Search for other papers by A Weisbrod in
Google Scholar
PubMed
Close
,
B Bian
Search for other papers by B Bian in
Google Scholar
PubMed
Close
,
M He
Search for other papers by M He in
Google Scholar
PubMed
Close
,
L Zhang
Search for other papers by L Zhang in
Google Scholar
PubMed
Close
,
A K Holloway Endocrine Oncology Section, Gladstone Institutes, Program in Reproductive and Adult Endocrinology, NIH/NCI/Surgery Branch, National Cancer Institute, NIH, Hatfield Clinical Research Center, Room 4‐5952, 10 Center Drive, Bethesda, Maryland 20892, USA

Search for other papers by A K Holloway in
Google Scholar
PubMed
Close
,
R Krishna
Search for other papers by R Krishna in
Google Scholar
PubMed
Close
,
N Nilubol
Search for other papers by N Nilubol in
Google Scholar
PubMed
Close
,
K Pacak Endocrine Oncology Section, Gladstone Institutes, Program in Reproductive and Adult Endocrinology, NIH/NCI/Surgery Branch, National Cancer Institute, NIH, Hatfield Clinical Research Center, Room 4‐5952, 10 Center Drive, Bethesda, Maryland 20892, USA

Search for other papers by K Pacak in
Google Scholar
PubMed
Close
, and
E Kebebew
Search for other papers by E Kebebew in
Google Scholar
PubMed
Close

( Zarnegar et al . 2006 ). The prevalence of malignant pheochromocytoma is 2.5–40%, and the overall survival rate is <50% at 5 years ( Zarnegar et al . 2006 ). Currently, there are no reliable histologic or molecular markers for distinguishing between

Free access
Sonia Cheng Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4
Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4

Search for other papers by Sonia Cheng in
Google Scholar
PubMed
Close
,
Wei Liu Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4

Search for other papers by Wei Liu in
Google Scholar
PubMed
Close
,
Moises Mercado Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4

Search for other papers by Moises Mercado in
Google Scholar
PubMed
Close
,
Shereen Ezzat Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4

Search for other papers by Shereen Ezzat in
Google Scholar
PubMed
Close
, and
Sylvia L Asa Department of Pathology, Servicio de Endocrinología, Department of Medicine, University Health Network and the Ontario Cancer Institute, 200 Elizabeth Street, 11th Floor, Toronto, Ontario, Canada M5G 2C4

Search for other papers by Sylvia L Asa in
Google Scholar
PubMed
Close

human liver diseases: utility as molecular markers for hepatocellular carcinoma . Journal of Hepatology 32 612 – 617 . Kondo T Ezzat S Asa SL 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia . Nature Reviews. Cancer 6

Free access
B Wängberg Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by B Wängberg in
Google Scholar
PubMed
Close
,
A Khorram-Manesh Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by A Khorram-Manesh in
Google Scholar
PubMed
Close
,
S Jansson Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by S Jansson in
Google Scholar
PubMed
Close
,
B Nilsson Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by B Nilsson in
Google Scholar
PubMed
Close
,
O Nilsson Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by O Nilsson in
Google Scholar
PubMed
Close
,
C E Jakobsson Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by C E Jakobsson in
Google Scholar
PubMed
Close
,
S Lindstedt Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by S Lindstedt in
Google Scholar
PubMed
Close
,
A Odén Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by A Odén in
Google Scholar
PubMed
Close
, and
H Ahlman Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by H Ahlman in
Google Scholar
PubMed
Close

ACC is an aggressive tumour disease with clinical course that can be difficult to predict also in patients with radically resected low-stage tumours ( Vassilopoulou-Sellin & Schultz 2001 ). Besides tumour staging and Weiss score, several molecular

Free access
Sofia K Gruvberger-Saal
Search for other papers by Sofia K Gruvberger-Saal in
Google Scholar
PubMed
Close
,
Heather E Cunliffe
Search for other papers by Heather E Cunliffe in
Google Scholar
PubMed
Close
,
Kristen M Carr
Search for other papers by Kristen M Carr in
Google Scholar
PubMed
Close
, and
Ingrid A Hedenfalk
Search for other papers by Ingrid A Hedenfalk in
Google Scholar
PubMed
Close

, prognosis, and treatment sensitivity, as well as traditional histopathological parameters. This review will focus on how the application of microarray-based technologies in the investigations of molecular markers has evolved from descriptive biological

Free access
Aura D Herrera-Martínez Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
Maimonides Institute for Biomedical Research of Cordoba (IMIBIC); Reina Sofia University Hospital, Córdoba, Spain

Search for other papers by Aura D Herrera-Martínez in
Google Scholar
PubMed
Close
,
Leo J Hofland Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

Search for other papers by Leo J Hofland in
Google Scholar
PubMed
Close
,
María A Gálvez Moreno Maimonides Institute for Biomedical Research of Cordoba (IMIBIC); Reina Sofia University Hospital, Córdoba, Spain

Search for other papers by María A Gálvez Moreno in
Google Scholar
PubMed
Close
,
Justo P Castaño Maimonides Institute for Biomedical Research of Cordoba (IMIBIC); Reina Sofia University Hospital, Córdoba, Spain

Search for other papers by Justo P Castaño in
Google Scholar
PubMed
Close
,
Wouter W de Herder Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Close
, and
Richard A Feelders Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Close

effect of the mTOR inhibitor everolimus and red arrows the effect of the tyrosine kinase inhibitor sunitinib. Molecular markers are presented in blue. Response to sunitinib has been related to decreased SDF1, IL-8, VEGFR 2-3, CD14 monocytes expressing

Free access
M Niedziela Department of Pediatric Endocrinology and Diabetes, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60–572 Poznan, Poland

Search for other papers by M Niedziela in
Google Scholar
PubMed
Close

’ of thyroiditis ( Loh et al. 1999 ). The question arises as to whether the thyroiditis preceded the nodule or vice versa. New data coming from molecular studies of the BRAF mutations, the molecular marker of PTC, indicate that the

Free access
Robert C Smallridge Division of Endocrinology, Department of Cancer Biology, Department of Internal Medicine

Search for other papers by Robert C Smallridge in
Google Scholar
PubMed
Close
,
Laura A Marlow Division of Endocrinology, Department of Cancer Biology, Department of Internal Medicine

Search for other papers by Laura A Marlow in
Google Scholar
PubMed
Close
, and
John A Copland Division of Endocrinology, Department of Cancer Biology, Department of Internal Medicine

Search for other papers by John A Copland in
Google Scholar
PubMed
Close

), the potential to integrate a-CGH results with histopathology and other molecular markers, and to relate the laboratory findings with patient diagnosis, prognosis, and therapy, will bring an individualized approach to cancer therapy in clinical practice

Free access
Chiara Villa Department of Neuropathology, Hôpital Universitaire Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France
Inserm U1016, CNRS UMR 8104, Institut Cochin, Université Paris Descartes-Université de Paris, Paris, France

Search for other papers by Chiara Villa in
Google Scholar
PubMed
Close
,
Bertrand Baussart Inserm U1016, CNRS UMR 8104, Institut Cochin, Université Paris Descartes-Université de Paris, Paris, France
Department of Neurosurgery, Hôpital Universitaire Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France

Search for other papers by Bertrand Baussart in
Google Scholar
PubMed
Close
,
Guillaume Assié Inserm U1016, CNRS UMR 8104, Institut Cochin, Université Paris Descartes-Université de Paris, Paris, France
Department of Endocrinology, Center for Rare Adrenal Diseases, Hôpital Cochin APHP, Paris, France

Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Close
,
Gerald Raverot Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, Bron, France
Lyon 1 University, Villeurbanne, France
Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Lyon, France

Search for other papers by Gerald Raverot in
Google Scholar
PubMed
Close
, and
Federico Roncaroli Geoffrey Jefferson Brain Research Centre, Division of Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom

Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
Close

molecular profiling in the classification of PitNETs Considerable progress has been made in the molecular characterisation of PitNETs but unlike other tumour types, the use of molecular markers has not entered diagnostic practice. In this respect, the

Free access
Adriana Albani Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Adriana Albani in
Google Scholar
PubMed
Close
,
Luis Gustavo Perez-Rivas Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Luis Gustavo Perez-Rivas in
Google Scholar
PubMed
Close
,
Sicheng Tang Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Sicheng Tang in
Google Scholar
PubMed
Close
,
Julia Simon Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Julia Simon in
Google Scholar
PubMed
Close
,
Kristin Elisabeth Lucia Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Kristin Elisabeth Lucia in
Google Scholar
PubMed
Close
,
Paula Colón-Bolea Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Paula Colón-Bolea in
Google Scholar
PubMed
Close
,
Jochen Schopohl Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Jochen Schopohl in
Google Scholar
PubMed
Close
,
Sigrun Roeber Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany

Search for other papers by Sigrun Roeber in
Google Scholar
PubMed
Close
,
Michael Buchfelder Department of Neurosurgery, University of Erlangen-Nürnberg, Erlangen, Germany

Search for other papers by Michael Buchfelder in
Google Scholar
PubMed
Close
,
Roman Rotermund Department of Neurosurgery, Universitätskrankenhaus Hamburg-Eppendorf, Hamburg, Germany

Search for other papers by Roman Rotermund in
Google Scholar
PubMed
Close
,
Jörg Flitsch Department of Neurosurgery, Universitätskrankenhaus Hamburg-Eppendorf, Hamburg, Germany

Search for other papers by Jörg Flitsch in
Google Scholar
PubMed
Close
,
Jun Thorsteinsdottir Neurochirurgische Klinik und Poliklinik, LMU Klinikum, Munich, Germany

Search for other papers by Jun Thorsteinsdottir in
Google Scholar
PubMed
Close
,
Jochen Herms Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany

Search for other papers by Jochen Herms in
Google Scholar
PubMed
Close
,
Günter Stalla Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany
Medicover Neuroendocrinology, Munich, Germany

Search for other papers by Günter Stalla in
Google Scholar
PubMed
Close
,
Martin Reincke Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Martin Reincke in
Google Scholar
PubMed
Close
, and
Marily Theodoropoulou Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Marily Theodoropoulou in
Google Scholar
PubMed
Close

normalization under pasireotide treatment ( Colao et al. 2012 , Witek et al. 2018 ). Recently, a consensus statement has highlighted the potential of USP8 mutational status as a molecular marker of pasireotide response ( Fleseriu et al. 2021 ). Our

Open access
Simona Falletta Department of Medical Science, Section of Endocrinology and Internal Medicine, University of Ferrara, Ferrara, Italy

Search for other papers by Simona Falletta in
Google Scholar
PubMed
Close
,
Stefano Partelli Pancreatic Surgery Unit, Pancreas Translational and Research Institute, San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy

Search for other papers by Stefano Partelli in
Google Scholar
PubMed
Close
,
Corrado Rubini Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy

Search for other papers by Corrado Rubini in
Google Scholar
PubMed
Close
,
Dominik Nann Institut fur Pathologie, University of Bern, Bern, Switzerland

Search for other papers by Dominik Nann in
Google Scholar
PubMed
Close
,
Andrea Doria Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy

Search for other papers by Andrea Doria in
Google Scholar
PubMed
Close
,
Ilaria Marinoni Institut fur Pathologie, University of Bern, Bern, Switzerland

Search for other papers by Ilaria Marinoni in
Google Scholar
PubMed
Close
,
Vanessa Polenta Pancreatic Surgery Unit, Pancreas Translational and Research Institute, San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy

Search for other papers by Vanessa Polenta in
Google Scholar
PubMed
Close
,
Carmelina Di Pasquale Department of Medical Science, Section of Endocrinology and Internal Medicine, University of Ferrara, Ferrara, Italy

Search for other papers by Carmelina Di Pasquale in
Google Scholar
PubMed
Close
,
Ettore degli Uberti Department of Medical Science, Section of Endocrinology and Internal Medicine, University of Ferrara, Ferrara, Italy

Search for other papers by Ettore degli Uberti in
Google Scholar
PubMed
Close
,
Aurel Perren Institut fur Pathologie, University of Bern, Bern, Switzerland

Search for other papers by Aurel Perren in
Google Scholar
PubMed
Close
,
Massimo Falconi Pancreatic Surgery Unit, Pancreas Translational and Research Institute, San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy

Search for other papers by Massimo Falconi in
Google Scholar
PubMed
Close
, and
Maria Chiara Zatelli Department of Medical Science, Section of Endocrinology and Internal Medicine, University of Ferrara, Ferrara, Italy

Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Close

including a very heterogeneous group of NET of different origin. Therefore, the results obtained by Benslama and coworkers may not reflect P-NET behavior ( Benslama et al . 2016 ). Besides putative molecular markers, we also investigated whether P

Free access